Ling-Long Tang Selected Research

Induction Chemotherapy

1/2022	Final Overall Survival Analysis of Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma: A Multicenter, Randomized Phase III Trial.
1/2022	The immune modulation effects of gemcitabine plus cisplatin induction chemotherapy in nasopharyngeal carcinoma.
1/2021	A Gene-Expression Predictor for Efficacy of Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma.
1/2021	Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial.
10/2020	A deep learning MR-based radiomic nomogram may predict survival for nasopharyngeal carcinoma patients with stage T3N1M0.
10/2020	Association between outcome disparities and pragmatic features related to clinical trial and real-world settings in nasopharyngeal carcinoma: A population-based retrospective cohort study, 2006-2016.
1/2020	Induction versus adjuvant chemotherapy combined with concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: A propensity score-matched analysis.
1/2020	Treatment effects of cumulative cisplatin dose during radiotherapy following induction chemotherapy in nasopharyngeal carcinoma: propensity score analyses.
10/2019	Development and validation of a novel MR imaging predictor of response to induction chemotherapy in locoregionally advanced nasopharyngeal cancer: a randomized controlled trial substudy (NCT01245959).
1/2019	The prolonged interval between induction chemotherapy and radiotherapy is associated with poor prognosis in patients with nasopharyngeal carcinoma.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ling-Long Tang Research Topics

Disease

106	Nasopharyngeal Carcinoma 07/2022 - 11/2004
26	Neoplasms (Cancer) 06/2022 - 02/2006
19	Neoplasm Metastasis (Metastasis) 01/2022 - 02/2006
7	Lymphatic Metastasis 12/2017 - 07/2007
5	Neutropenia 01/2021 - 11/2016
4	Infections 06/2022 - 01/2014
4	Necrosis 01/2022 - 11/2008
3	Carcinogenesis 01/2022 - 10/2013
3	Hypothyroidism 01/2020 - 11/2018
3	Mucositis 05/2018 - 03/2017
3	Stomatitis 12/2017 - 02/2012
2	Squamous Cell Carcinoma of Head and Neck 06/2022 - 12/2017
2	Lung Neoplasms (Lung Cancer) 06/2022 - 11/2018
2	Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) 10/2019 - 01/2016
2	Vomiting 01/2019 - 11/2018
2	Anemia 01/2019 - 12/2017
2	Nausea 01/2019 - 11/2018
2	Xerostomia 03/2017 - 10/2015
2	Inflammation (Inflammations) 03/2016 - 01/2016
2	Atrophy 12/2015 - 08/2015
1	Extranodal Extension 07/2022
1	Melanoma (Melanoma, Malignant) 06/2022
1	Dermatomyositis (Dermatopolymyositis) 01/2022
1	Disease Progression 01/2022
1	Residual Neoplasm 01/2022
1	Optic Nerve Diseases (Optic Neuropathy) 01/2022
1	Hand-Foot Syndrome 01/2021
1	Thrombocytopenia (Thrombopenia) 01/2019
1	Pneumonia (Pneumonitis) 11/2018
1	Arthralgia (Joint Pain) 11/2018
1	Carcinoma (Carcinomatosis) 03/2018
1	Head and Neck Neoplasms (Head and Neck Cancer) 12/2017
1	Spasm (Spasms) 11/2017
1	Hearing Loss (Hearing Impairment) 03/2017
1	Leukopenia 03/2017
1	Weight Loss (Weight Reduction) 11/2015
1	AIDS-Related Complex (ARC) 01/2015
1	Mastoiditis 01/2015
1	Cranial Nerve Diseases (Cranial Nerve Disorders) 06/2013
1	Peripheral Nervous System Diseases (PNS Diseases) 06/2013
1	T-Cell Lymphoma (Lymphoma, T Cell) 02/2013
1	Liver Failure 03/2012

Drug/Important Bio-Agent (IBA)

19	DNA (Deoxyribonucleic Acid)IBA 07/2022 - 01/2015
14	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 02/2012
10	Biomarkers (Surrogate Marker)IBA 01/2022 - 03/2014
4	Fluorouracil (Carac)FDA LinkGeneric 01/2019 - 02/2012
3	Gemcitabine FDA Link 01/2022 - 01/2019
3	Immune Checkpoint InhibitorsIBA 11/2021 - 11/2018
3	MicroRNAs (MicroRNA)IBA 06/2020 - 10/2013
3	Docetaxel (Taxotere)FDA Link 01/2019 - 11/2016
2	PlatinumIBA 06/2022 - 01/2019
2	Messenger RNA (mRNA)IBA 06/2022 - 01/2018
2	Adrenal Cortex Hormones (Corticosteroids)IBA 06/2022 - 01/2021
2	nitazoxanide (NTZ)FDA Link 05/2018 - 01/2018
2	ErbB Receptors (EGF Receptor)IBA 05/2018 - 01/2018
2	Cetuximab (Erbitux)FDA Link 01/2018 - 01/2018
2	nimotuzumabIBA 01/2018 - 01/2018
2	GlobulinsIBA 01/2016 - 01/2014
2	AlbuminsIBA 01/2016 - 01/2014
2	Serum AlbuminIBA 11/2015 - 01/2014
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 09/2013 - 03/2012
1	Carrier Proteins (Binding Protein)IBA 06/2022
1	Glutathione (Reduced Glutathione)IBA 06/2022
1	GlycosphingolipidsIBA 06/2022
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 06/2022
1	Insulin-Like PeptidesIBA 06/2022
1	Peptide Initiation Factors (Initiation Factor)IBA 06/2022
1	TOR Serine-Threonine KinasesIBA 06/2022
1	Angiogenesis InhibitorsIBA 01/2022
1	16S Ribosomal RNAIBA 01/2022
1	apatinibIBA 01/2022
1	Long Noncoding RNAIBA 01/2022
1	Capecitabine (Xeloda)FDA Link 01/2021
1	CortactinIBA 01/2020
1	Tumor Biomarkers (Tumor Markers)IBA 12/2018
1	pembrolizumabIBA 11/2018
1	NivolumabIBA 11/2018
1	atezolizumabIBA 11/2018
1	Monoclonal AntibodiesIBA 01/2018
1	Antiviral Agents (Antivirals)IBA 09/2017
1	EnzymesIBA 09/2017
1	Uric Acid (Urate)IBA 01/2017
1	Serum GlobulinsIBA 01/2016
1	C-Reactive ProteinIBA 01/2016
1	VX (EDIM)IBA 12/2015
1	Membrane Proteins (Integral Membrane Proteins)IBA 10/2015
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2014
1	LuciferasesIBA 02/2013

Therapy/Procedure

46	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 07/2022 - 07/2007
33	Radiotherapy 01/2022 - 02/2006
26	Induction Chemotherapy 01/2022 - 11/2016
25	Chemoradiotherapy 01/2022 - 08/2008
17	Therapeutics 06/2022 - 01/2015
16	Drug Therapy (Chemotherapy) 01/2021 - 08/2008
6	Adjuvant Chemotherapy 01/2021 - 08/2008
5	Aftercare (After-Treatment) 01/2022 - 03/2012
5	Neoadjuvant Therapy 03/2017 - 01/2015
3	Immunotherapy 01/2022 - 09/2017
1	Lasers (Laser) 12/2017
1	Conformal Radiotherapy 11/2004